A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes

Authors: Xi Wang, Kristina G. Maxwell, Kai Wang, Daniel T. Bowers, James A. Flanders, Wanjun Liu, Long-Hai Wang, Qingsheng Liu, Chengyang Liu, Ali Naji, Yong Wang, Bo Wang, Jing Chen, Alexander U. Ernst, Juan M. Melero-Martin, Jeffrey R. Millman, Minglin Ma

Published: 2021-06-02

DOI: 10.1126/scitranslmed.abb4601

Source: Full article


Abstract

A nanofibrous cell encapsulation device containing rodent/human islets or human stem cell–derived β cells treats diabetes in rodents.